Kathi Niffenegger
2023
In 2023, Kathi Niffenegger earned a total compensation of $453.4K as Former Chief Financial Officer at Edesa Biotech, a 16% decrease compared to previous year.
Compensation breakdown
Bonus | $102,080 |
---|---|
Option Awards | $49,488 |
Salary | $253,391 |
Other | $48,414 |
Total | $453,373 |
Niffenegger received $253.4K in salary, accounting for 56% of the total pay in 2023.
Niffenegger also received $102.1K in bonus, $49.5K in option awards and $48.4K in other compensation.
Rankings
In 2023, Kathi Niffenegger's compensation ranked 1,745th out of 2,238 executives tracked by ExecPay. In other words, Niffenegger earned more than 22.0% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 1,745 | 22nd |
Manufacturing | 983 | 19th |
Chemicals And Allied Products | 586 | 14th |
Drugs | 570 | 13th |
Pharmaceutical Preparations | 410 | 13th |
Niffenegger's colleagues
We found three more compensation records of executives who worked with Kathi Niffenegger at Edesa Biotech in 2023.
News
Edesa Biotech CEO Pardeep Nijhawan's 2023 pay slips 9% to $550K
April 5, 2024
Edesa Biotech CEO Pardeep Nijhawan's 2022 pay falls 54% to $602K
March 28, 2023
Edesa Biotech CEO Pardeep Nijhawan's 2021 pay jumps 221% to $1.3M
April 1, 2022
Edesa Biotech President Michael Brooks' 2020 pay jumps 155% to $529K
March 3, 2021
Edesa Biotech President Michael Brooks' 2019 pay slips 10% to $207K
March 23, 2020